|
Adams,MJ Reichel, MB King, IA Marsden, MD
Characterization of the regulatory regions in the human desmoglein genes encoding the PF & PV antigens
Biochem J 329(pt 1);165-174 1998 PF, PV, desmoglein gene
Akhtar, SJ Hasan ,MU
Treatment of pemphigus a local experience
J Pak Med Assoc 48(10);300-4 1998 Oct PV, PF, PVeg, PE, treatment
Amagai, M Nishikawa,T Nousari, H Anhalt, GJ, & Hashimoto,T
Antibodies against Desmoglein 3 are present in Sera form patients with PNP and cause acantholysis in neonatal mice
J Clin Invest 102;775-782 1998 Dsg 3, PNP, etiology
Amos B Deng J-S Flynn K Suarez S
BP in infancy: case report and literature review
Ped Dermatol 15;108-11 1998 BP, children, infants, review,
Anhalt, GJ
Go easy on the prednisone in pemphigus, expert says
Skin&Allergy News page 28 1998 June treatment, prednisone
Brenner,S Bialy-Golan, A Ruocco,V
Drug induced Pemphigus
Clin.in Dermatol. 16;393-397 1998 drug induced, DIP, PV, PF
Brenner,S Dorfman,B Himelfarb,M
Familial PV
Dermatologica 171;38-40 1985 PV, family, relatives
Brenner,S Dorfman,B Himelfarb,M
Familial PV
Dermatologica 171;38-40 1985 PV, family, relatives
Budinger,L Borradori,L Yee,C Eming,R, et al, Hertl,m
Identification & characterization of autoreactive T cell responses to BP antigen 2 in patients & healthy controls
J Clin Invest 102;2082-89 1998 BP, T cell, BPAG2, Th1, Th2, HLA-DQB1*0301
Camisa,C Warner,M
Treatment of Pemphigus
Dermatol. Nursing 10;115-131 1998 PV, PVeg, PF, PE, DIP, PH, ParaP
Cathomas,G Stalder,A Regamey,N Erb,P, et al
No evidence of HHV-8 infection in patients with PV/F
Arch Dermatol 134;1162 1998 PV, PF, HV
Chan,E Thakur,A Farid,L Lessin,S, et al
PV of the Cervix & Upper Vaginal Vault; a cause of atypical Papanicolaou Smears
Arch Dermatol 134;1485-86 1998 PV, vagina, Pap, cervix
TOP
Chan,LS Vanderlugt,CJ Hashimoto,T Nishikawa,T, et al
Epitope spreading; Lessons from autoimmune skin diseases
J Invest Dermatol 110;103-109 1998 epitope spread, PV, autoimmunity
Chiou,AG-Y Florakis,GJ Kazim,M
Management of Conjuntival cicatrizing disease & severe ocular surface dysfunction
Sur. Ophth 43;19-46 1998 conjuctiva, OCP, CP, cicatrizing disease
Colonna,L Cianchini,G Frezzolini,A Pita,OD, Lella,GD, Puddu,P
Intravenous immunoglobulins for PV;aduvant or first choice therapy
Br.J.Dermatol. 138;1102-1103 1998 PV, IVIG, treatment
Cremniter,D Baudin,M Roujeau,J-C Prost,C e al
Stressful Life events as potential triggers of Pemphigus
Arch Dermatol 134;1486-1487 1998 PV, PF, stress, trigger
Dematology Foundation: Diaz,LA Stanley,JR
Pemphigus;The pathologic relationship between autoimmune antibody& antigen
Dermatol. Focus 17(2);1-7 1998 PV, PF antibody, antigen
Drouet,M Delpuget-Bertin,N Vaillant,L Chauchaix,S, et al
HLA-DRB1 & HLA-DQB1 genes in susceptibility & resistence to cicatricial pemphigoid in French Caucasians
European J Dermatol 8; 1085-90 1998 HLA, CP,
Grosso do Sul,
Brazil
J Med Entomol. 35;120-31 1998
PF, Fogo Selvagem, black fly, etiology
Enk,AH Knop,J
Adjuvant therapy of PV & PF with intravenous immunoglobulins (German)
Hautarazt 49(10);774-6 1998 Oct PV, PF, IVIG
Gniadecki,R Jemec,GB Thomsen,BM Hanson,M
Relationship between keratinocyte adhesion & death; anoikis in acantholytic disease
Archives of Dermatol. Reasearch 290(10);528-32 1998 Oct PV, PF
Gonzalez-Escribano,MF Jimenez, G Walter,K Perez-Bernal,AM, et al
Distribution of HLA classII alleles among Spanish patients with pemphigus
Tissue Antigens 52(3);275-8 1998 Sep PV, HLA, MHC
Gooptu,C Staughton,RCD
Use of topical cyclosporin in oral pemphigus
J. of the Am. Acad. of Dematol. 38;860-861 1998 PV, oral
involvement, cyclosporine
Haase,C Budinger,L Borradori,L Yee,C, et al, Michael Hertl
Detection of IgG autoantibodies in the sera of patients with BP & GP (gestational pemphigoid); ELISA studies utilizing a baculovirus-encoded for of BP antigen 2
J Invest Dermatol 110;282-286 1998 BPAG2, BP, GP
TOP
Hern,S Vaghan-Jones,SA Setterfield,J DuPeloux-Menag,H, et al
PV in pregnancy with favourable foetal prognosis
Clin & Exp Dermatol 23;260-3 1998 PV, pregnancy
Hertl,M Amagai,M Sundaram,H Stanley,J, et al
Recognition of Desmoglein 3 by Autoreactive T cells in PV patients & normals
J Invest Dermatol 110;62-66 1998 PV, Dsg 3, DRB1*0402
Hertl,M Karr,RW Amagai,M Katz,SI
Heterogeneous MHC II restriction pattern of autoreactive Desmoglein 3 specific T cell responses in PV patients & normals
J Invest. Dermatol 110;388-92 1998 PV, Dsg 3, DRB1*0402, T cell
Ichimiya,M Yamamoto,K Muto,M
Successful Rx of Pemphigus vegetans by addition of etretinate to systemic steroids
Clin.& Experiment. Dermatol. 23(4);178-80 1998 Jul PVeg, etretinate
Izumi,T Seishima,M Satoh,S Ito,A, & Kamiya,H
Pemphigus with features of both vulgaris & foliaceus variants, associated with antibodies to 160 & 130 kDa antigen
Brit. J Dermat. 139(4);688-92 1998 Oct PV, PF, antibodies
Jolles S Hughes J Whittaker S
Dermatological uses of high-dose IVIg
Arch Dermatol 134;80-86 1998 IVIg, PV, PF,
Kao,HC et al
PV
Chung-Hua 39(6);404-5 1998 Nov-Dec PV
|
Kiyokawa,C Fujito,S Mori,O Mochizuki,M, et al
BP showing unusual ocular changes
Br J Dermatol 139;693-96 1998 BP, eyes, cornea,
Korman NJ
Bullous pemphigoid- the lastest in diagnosis, prognosis, and therapy Arch Dermatol 134;1137-41 1998 BP, review, TPMT,
Kyriakis,KP Tosca,AD
Epidemiologic observation on the natural
course of PV
Inter.J. Dermatol. 37-215-219 1998 PV, natural course
Lapiere,J-C Guitart,J Ettlin,DA Chen,DM, et al
Preferential activation of the complement system inthe lower epidermis of patients with PV
Brit J Dermatol 139;851-854 1998 PV, compliment
TOP
Lee,CW Yang,HY Kim,JH Hwang,JJ
HLA class II allele association in Korean patients with Pemphigus Dermatol 197;349-52 1998 HLA, Korean, DRB1*01, PV, PF,
Leverkus,M Schmidt,E Lazarova,Z Brocker,E-B, et al
Antiepiligrin Cicatricial Pemphigoid
Arch Dermatol. 135;1091-8 1999 CP, AECP, lamina 5,
Lin,M-S Liu,Z Diaz,LA
Cutaneous Autoimmune Diseases The Autoimmune Diseases,
3rd ed. NR Ross & IR Mackay editors, Academic press Chapter 27,
p545-70 1998 PV, PF, BP, CP, T cell activation,
Lynch,D
A review of cicatricial pemphigoid
www.gumdr.com/gumdr/98_05.htm 1998 CP
Mahoney,MG Aho,S Uitto,J Stanley,JR
The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin
J Invest Dermatol 111;308-13 1998 Aug plakin, ParaP, antibodies
McKusick,V Cagas,PM
Desmoglein 3, PV antigen
www.ncbi.nlm.nih.ov/htbin-post/Omim 1998 Dsg 3,PV,
Memar,OM
The target in PV
The National Pemphigus Foundation web site 1998 PV, antigen, dsg3,
Nguyen,VT Lee,TX Ndoye,A Shultz,LD, Pittelkow,MR, Dahl,MV, Lynch,PJ, & Grando,SA
The pathophysiologic significace of nondesmoglein targets of
pemphigus autoimmunity
Arch.Dermatol. 134;971-980 1998 Aug. pemphigus, antibodies, etiology
Pacor,ML Biasi,D Carletto,A Maleknia,T, et al
Topical cyclosporine in the treatment of oral pemphigus
Minerva Stomatol 47;183-6 1998 oral involvement, PV, cyclosporine
Pandya,A Dyke,C
Treatment of Pemphigus with Gold
Arch Dermatol 134;1104-07 1998 gold,PV, PF
Prabhakar,BS
Antibody production
National Pemphigus Foundation web site 1998 antibodies, HLA,
Reichert-Penetrat,S Barbaud,A Martin,S Omhover,L, et al
PV on an old surgical scar; Kooebner's phenomenon
Eur J Dermatol 8;60-2 1998 PV, Koebner's phenonenon, etiology
TOP
Roujeau,J Lok,C Bastuji-Garrin,S Mhalla,S et al
High risk in elderly patients with extensive Bullous Pemphigoid
Arch Dermatol 134;465-469 1998 BP, death
Sapadin,AN Anhalt,GJ
Paraneoplastic pemhigus with a pemphigus vegitans-like plaque as the only cutaneous manifestation
J Am Acad Dermatol 39;867-71 1998 ParaP, PVeg
Schoen,H Foedinger,D Derfler,K Amann,G et al
Immunoapheresis in Paraneoplastic Pemphigus
Arch Dermatol 134;706-710 1998 ParaP, Immunoapheresis
Setterfield,J Shirlaw,PJ Ker-Muir,M Neil,S, et al
Mucous membrane pemphigoid; a dual circulating antibody response with IgG & IgA signifies a more severe & persistent disease
Br J Dermatol 138;602-610 1998 Mucous membrane pemphigoid, IgG, IgA
Shirahama,S Furukawa,F Takigawa,M
Recurrent PV limited to the surgical area after mastectomy
J Am Acad Dermatol 39;352-5 1998 PV, etiology
Shirakata,Y Amagai,M Hanakawa,Y Nishikawa,T, e al
Lack of mucosal involvement in PF may be due to low expression of Desmoglein 1
J Invest. Dermatol 110;76-78 1998 PF, Dsg 1,
Sklavounou,A Laskaris,G
Paraneoplastic pemphigus ;a review
Oral Oncology 34 (6); 437-40 1998 Nov ParaP
Smith,KJ Skelton,HG
Human Herpesvirus 8 DNA sequences in pemphigus
Arch dermatol 134;751 1998 virus, HHV, PV
Starzycki,Z Chorzelski,TP Jablonska,S
Familial PV in mother & daughter
Int J Dermatol 37;211-14 1998 family, familial, PV, inherited
Tehranchi-Nia,Z Qureshi,TA Ahmed,AR
PV in older adults
J.Am.Geriat.Soc. 46;92-94 1998 PV
Tomasini,D Cerri,A Cozzani,E Berti,E
Development of PF in a patient with psoriasis;a simple coincidence? Eur.J.Dermatol. 1;56-59 1998 PF, psoriasis
Tur,E Brenner,S
Diet & pemphigus
Arch.Dermatol. 134;1406-1410 1998 PV, PF, diet, Etiology
Vaillant,L Bernard,P Joly,P Prost,C et al
Evaluation of clinical criteria for diagnosis of Bullous Pemphigoid
Arch Dermatol 134;1075-80 1998 BP
Wucherpfennig,K.
Peptid-based therapy for the treatment of PV
National Pemphigus Foundation web site 1998 PV, peptide-based,
TOP
|
